Anhydrate forms of a pyridine derivative

Details for Australian Patent Application No. 2010288502 (hide)

Owner GlaxoSmithKline LLC

Inventors Craig, Andrew Simon; Ismail, Salima Zarah; Lawrence, Ronnie Maxwell

Agent Davies Collison Cave

Pub. Number AU-A-2010288502

PCT Pub. Number WO2011/023733

Priority 61/237,435 27.08.09 US

Filing date 25 August 2010

Wipo publication date 3 March 2011

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 February 2012 PCT application entered the National Phase

  PCT publication WO2011/023733 Priority application(s): WO2011/023733

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010288505-Reminder device for a pen -shaped medical delivery device

2010288482-Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis